Achieving Desired Particle Size And Yield Through Efficient Micronization

Micronization is a particle engineering technique that reduces solid particles to the sub-micron or micron range, typically 1–10 microns in diameter, offering significant benefits for pharmaceutical development. This size reduction enhances the solubility, dissolution rate, and bioavailability of the active pharmaceutical ingredient (API), improving the performance of the final drug product. Additionally, smaller particle sizes enhance flow properties and handling, simplifying manufacturing and processing.

In this webinar, experts will explore how the right combination of advanced technology and specialized expertise can leverage micronization to address the challenges often faced by small molecule drugs. Topics will include overcoming hurdles in scaling, optimizing yields, and managing the cost of goods for API particle engineering, from formulation development to commercial supply, ensuring efficient and successful drug production.